Analytical Tool - Protein Kinase
Inhibitors in Oncology" offers a unique tool for analyzing the vast amount
of strategic possibilities that have emerged in the drug development of protein
kinase inhibitors (PKIs) for the treatment of cancer. It is at the same time a
map of the research and development, a history of the achievements up to date,
and a guide pointing out the directions of the future. The product as well,
lays the framework of current treatment strategies and their progress. This
tool provides you with an immense amount of information structured and analyzed
to assist you in your work. It is designed to assist you in finding right
partners, optimizing your licensing deals, wisely choosing which projects give
you the best competitive advantage, and assuring you that your decisions have
been based on the most accurate, validated and precise facts available.
Included in this advantageous
package are two products already appreciated by many of our customers:
Competitive Insights to Protein
Kinase Therapeutics in Oncology: The Faster Route to Consider Your Options and
Position of Others
Protein Kinase Inhibitors in
Oncology: Drug Pipeline Update 2013*
The Package Includes
* A progress analysis on current and
emerging drugs
* Information on most companies
active in the development of PKIs in oncology
* Information on key industry
related PKI drug projects in oncology
* Data from most important clinical
trials
* Information on early developmental
stage projects
* Possibility of performing advanced
searches suited to your individual needs
This Tool will Assist You in:
* Tracking cutting edge companies,
therapies and new technologies
* Rapid identification of partners
& competitors
* Laying down a comprehensive
framework for further analysis of the field
* Producing presentations
surrounding the development of PKI drugs in oncology
* Identifying emerging PKI cancer
products & key areas of pharmaceutical R&D
This software application is a
searchable database reflects the most recent advances in the field of PKI drug
development in cancer, in order to help you perform your own analysis, go back
to the source data for in-depth information, and present the research and development
in tables and graphs suited for your own specific purposes. A significant
advantage with BioSeeker's software applications is that they provide you with
well-structured information. Each pipeline drug/project has been carefully
defined and classified in categories and subcategories. The main categories
include therapy type, effect, mechanism of action (molecular target),
indication, stage of development etc. These categories are further organized
and classified in sub-categories. In comparison with other available databases,
BioSeekers software applications give better overview, specific search
capabilities and great dynamic reports.
To order this report:
Email: customerservice@researchonglobalmarkets.com
US:
+1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE: Researchonglobalmarkets.com
RELATED LINK:
RELATED VIDEO:
No comments:
Post a Comment